An investigation for investors in NASDAQ:NOVN shares was announced concerning possible securities laws violations by Novan Inc NASDAQ:NOVN in connection certain financial statements.
Investors who purchased shares of Novan Inc NASDAQ:NOVN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Novan Inc (NASDAQ:NOVN) concerning whether a series of statements by Novan Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Shares of Novan Inc (NASDAQ:NOVN) reached as high as $29.06 per in December 2016.
On January 27, 2017, Novan Inc NASDAQ:NOVN) announced top-line results from the Company’s two, replicate Phase 3 pivotal clinical trials for SB204 in the treatment of acne vulgaris. Shares of Novan Inc (NASDAQ:NOVN) dropped on January 27, 2017 to as low as $3.52 per share.
Those who purchased NASDAQ:NOVN shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Leave Your Comments